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INTRODUCTION
Dry eye disease or keratoconjunctivitis sicca is a multifactorial 
disease that is developed due to inflammation of the ocular surface 
and lacrimal glands, meibomian gland dysfunction, and neuropathic 
pain disorder [1]. Various environmental factors such as air dryness, 
smoke, allergens, systemic diseases, and age (in premenopausal 
women) contribute to DED [2-5]. The disease has increased in recent 
years with the advent of monitors and prolonged use of computers 
and is one of the most important causes of referral to ophthalmology 
clinics characterised by symptoms such as scratches and foreign 
bodies in the eye [6-8].
Due to the high prevalence of DED, it is necessary for 
physicians to have important information about care, often 
debilitating symptoms, and preventable and curable nature of 
the disease [5].
DED treatment is based on a tear substitute. New treatments 
focus on certain drugs such as secretagogues, lubricants, topical 
androgens, antibiotics, immunosuppressive drugs, and new anti-
inflammatory drugs [9,10]. Meanwhile, herbal treatments have been 
used in the treatment of various diseases due to being less costly 
and causing fewer side effects [11-19]. Although, the use of herbal 
medicines has been used in many countries for the treatment of 
eye diseases since long time [20-23], however, little information is 
available on the validity of the efficacy or probable side effects of 
these drugs. Also, regarding the high prevalence of the disease, 
and considering that there is still no study in this regard, the authors 
aimed to investigate the effect and mechanism of medicinal plants 
in treating DED in the present systemic review.
MATERIALS AND METHODS
The key words ‘Dry eye’ or ‘Keratoconjunctivitis sicca’ or ‘keratitis 
sicca’ in combination with medicinal plant, herb, and phyto were 
used to conduct the review. Relevant articles (from 2000 till date) 
were retrieved by using keywords from databases including ISI, 
PubMed, and Scopus with EndNote software. Then, the plants and 
the plant-based products that were effective on DED were selected 
and entered to the study according to inclusion criteria. A standard 
form, which included items such as year of publication, aim and 
the title of the study, intervention, outcome, variables, journal name, 
period, and number, was designed. The articles contents that were 
in accordance with the purpose of the study were recorded in the 
form and entered to the study with agreement of researchers. The 
articles whose full texts were not accessible, the articles published 
in non-English languages, and those that did not address the 
subject of this review were excluded after the author’s agreement 
was achieved. [Table/Fig-1] is the flowchart that illustrates how the 
articles were selected for final analysis.
RESULTS
The 17 studies that were included in the review and were effective 
on treatment on DED are tabulated in [Table/Fig-2] [24-40].
DISCUSSION
Dry eye disease is a multifactorial disease. Hence, the treatment 
must be based on underlying cause of the disease. Medicinal plants 
and their derivatives can impact DED in several ways. Medicinal 
plants improve tear film stability by decreasing osmolality and 
inflammation increasing tear production. Tear hyperosmolarity 
has been reported to begin dry eye inflammation through the 
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ABSTRACT
Introduction: Dry Eye Disease (DED) is one of the most common 
problems and reasons for referring to ophthalmology clinics, 
which has been exacerbated by the increased use of computers 
and mobile phones.
Aim: The purpose of the present systemic review was to 
review the effects and mechanism of medicinal plants in DED 
treatment.
Materials and Methods: The key words “Dry eye” or 
“Keratoconjunctivitis sicca” or “keratitis sicca” in combination 
with “medicinal plant”, “herb”, and “phyto” were used to 
conduct the review. Clinical and experimental published articles 
in English language between 2000-2018 were retrieved from 
databases including the Institute for Scientific Information (ISI), 
PubMed and Scopus.
Results: Totally, 199 articles were retrieved from the electronic 
database and finally 17 articles were included in the final 
analysis. Various plants such as Buddleja officinalis, Aristotelia 
chilensis, Prunus armeniaca, Hippophae rhamnoides, Lycium 
barbarum, and Rhynchosia volubilis Lour are effective in treating 
DED through different mechanisms.
Herbal derivatives such as curcumin, antioxidant glasses, 
phytoestrogen, ferulic acid, and kaempferol can be used as 
food supplement independently and in some cases along with 
chemical drugs. Chinese herbal formulations and compounds 
such as ‘Chi-Ju-Di-Huang-Wan’, ‘TriphalaGhritaNetratarpan’, 
and ‘ShengJinRunZaoYangXue’ granules can play a role in 
inducing anti-oxidant and anti-inflammatory properties in the 
treatment of the disease.
Conclusion: Generally, medicinal plants reduce tear film stability 
by decreasing osmolarity and increasing tear production. 
Several mechanisms, including the reduction of Reactive 
Oxygen Species (ROS) (antioxidant activity), the prevention 
of cell apoptosis, the modulation of inflammatory factors, and 
the regulation of androgens, can affect lacrimal glands and 
membrane cells, thereby helping to treat DED.
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activation of epithelial and stromal cells on the ocular surface, 
which increase the presence of pro-inflammatory cytokines [41]. 
Inflammation can cause dysfunction in the lacrimal glands cells 
responsible for tear secretion or retention and leads to ocular 
surface disease. Plant compounds can be used to regulate levels 
of gonadal hormones by exhibiting androgen-like activities. As 
a result, it can inhibit topical inflammation in the lacrimal glands 
and reduce cell apoptosis [41,42]. In addition, plants and their 
compounds can contribute to the treatment process by inhibiting 
the expression of pro-inflammatory cytokines (IL-1 beta, IL-6, and 
TNFα) and reducing nitric oxide production [30,43,44]. Artificial 
tears are the most common treatment for eye diseases therapy; 
they provide temporary symptomatic relief; however, are unable 
inhabitation of inflammatory cytokines activity [34]. Also, reduction 
of ROS (antioxidant activity) and the prevention of cell apoptosis 
can reduce the symptom of DED. A 8-Hydroxy-2 deoxyguanosine 
(8-OHdG), 4-Hydroxynonenal (HNE) and Malondialdehyde (MDD) 
are major biomarkers that cause oxidative damage in ocular 
surface [41,45]. In DED patients, the levels of these in the tear 
and conjunctiva increase and cause disruption in the normal 
functioning of the eye and finally leads to oxidative damage, 
possibly inflammation and apoptosis [41]. Anti-apoptotic activity 
and increased expression of some genes in the lacrimal gland 
epithelial cells represent one of the mechanisms in treating DED 
[46]. Medicinal plants indicate androgen-like activity and can 
affect lacrimal glands and membrane cells, thereby contributing 
to DED treatment. Androgens may increase meibomian gland 
function and lacrimal gland function [47].[Table/Fig-1]: Flowchart of the process of selecting and analysing the articles.
Medicinal plants
references Plants Study design type of administration Main effects or mechanisms
Peng QH et al., [24] Buddleja officinalis Experimental (in vivo) Extract
Displaying androgen-like activity to keep 
basic tears secretory volume and tear 
film stability
Hitoe Set al., [25] Aristotelia chilensis Clinical pilot trial
standardised extract 
(MaquiBright)
Increasing tear fluid volume
Kim CS et al., [26] Prunus armeniaca Experimental (in vivo) Kernel extract
Promoting the secretion of tear fluid and 
mucin
Kimura Y et al., [27] Hippophae rhamnoides Experimental (in vivo) Pulp oil
Preserving tear secretion and 
inflammatory cytokines in the lacrimal 
gland
Chien KJ et al., [28] Lycium barbarum Experimental (in vivo) Extract
Enhancing the tear volume and repairing 
the damaged ocular surface cells 
by exhibiting antioxidant and anti-
inflammatory activity.
Kang SW et al., [29] Rhynchosia volubilis Lour. Experimental (in vivo) Ethanol extract
Inhibiting squamous metaplasia and 
apoptosis in the cornea and inhibiting the 
expression of cytochrome c and Bax, 
while improving that of Bcl-2.
Phytochemicals
references
Phytocompound and plant 
deravities
Origin Study design Main effects or mechanisms
Chen M et al., [30] Curcumin Turmeric (Curcuma longa) Experimental (in vivo)
Protecting against hyperosmoticity-
induced IL-1b elevation in human corneal 
epithelial cell via the MAPK pathways and 
producing anti-inflammatory effect
Scuderi G et al., [31]
Lacrisek (phytoestrogen 
compound)
a-lipoic acid (100 mg), eicosapentaenoic 
acid (240 mg), and extract of fenugreek 
(200 mg), which contains diosgenin 
(1.3%), steroidal saponins (50%), and 
alkaloids
Randomised clinical 
trial
Decreasing tear osmolarity and 
significantly increasing tear production
Choi W et al., Choi W 
et al., and Huang JY 
et al., [32-34]
Antioxidant glasses
Extract of Schizonepetatenuifolia 
var. japonica Kitagawa, Angelica 
dahurica Bentham ET hooker, 
RehmanniaglutinosaLiboschitz var. 
purpurea Makino, and Cassia tora 
L extracts/Cassiae semen and 
Ophiopogonisjaponicus
Randomised Clinical 
trial/Experimental (in 
vivo)
Exerting preventive effect on membrane 
damage, and inflammation in DED 
byimprovingall clinical parameters, IL-1β, 
IL-6, TNF-α, and IFN-γ levels, percentage 
of CD4+CXCR3+ T cells, goblet cell 
density, number of 4-HNE-positive cells, 
and extracellular reactive oxygen species 
(ROS) production
Chen HC et al., [35] Ferulic acid and kaempferol - Experimental (in vitro)
Ferulic acid and kaempferollower IL-1B, 
IL-6, IL-8, and TNFα expression and 
produce antioxidant effect
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Clearly, it should be noted that some herbs did not have any 
positive effect on DED treatment (in humans or animals) [48,49]. 
Anticholinergic alkaloids are one of the strongest causes of the 
disease [50]. The most important plant compounds that lead 
to the development of DED include niacin, echinacea, and kava, 
and it should be noted that herbal drugs per se can cause eye 
complications for consumers, which is due to the natural origin of 
these products, are usually ignored by the consumers and even by 
the doctors who prescribe the herbal drugs [51,52].
For example, pouring black tea (Camellia sinensis) directly into the 
cornea with the corneal epithelial defect should be prevented, as it 
leads to anterior stromal discolouration in individuals [53]. On the 
other hand, determining the effective dose of medicinal plants is 
another factor affecting their efficacy. Determining the effective dose 
in DED treatment means the determination of dose for the highest 
efficacy and also in the toxic dose [28,35].
In some studies, this issue has been neglected and different 
quantities of plant extract or derivatives at different intervals have 
not been studied, which was one of the major problems with these 
studies [54,55].
CONCLUSION
Medicinal plants improve tear film stability by decreasing osmolality 
and increasing tear production. Several mechanisms, including 
the reduction of ROS (antioxidant activity), the prevention of 
cell apoptosis, the modulation of inflammatory factors, and the 
regulation of androgens, can affect lacrimal glands and membrane 
cells, thereby contributing to DED treatment.
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